Data as of Q4 2025 (Dec 31, 2025)

CARIS LIFE SCIENCES, INC.

(CAI)

Financial Statements · SEC EDGAR XBRL

Revenue
$812.0M
+97.0%
Net Income
-$68.1M
+75.8%
EPS
$-3.22
+69.8%
Op. Income
$45.1M
+117.5%
FCF
$66.9M
+126.4%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Operating Expenses & Income
Research & Development
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
$812.0M
$412.3M
$306.1M
$812.0M
$412.3M
$306.1M
$101.6M
$113.9M
$116.9M
$45.1M
-$257.1M
-$319.6M
-$113.2M
-$24.8M
-$21.9M
-$68.1M
-$281.9M
-$341.4M
$0
$0
$0
-$68.1M
-$281.9M
-$341.4M
$-3.22
$-10.66
$-13.24
$-3.22
$-10.66
$-13.24
167.2M
35.5M
34.9M